Privia Health Is Maintained at Equal-Weight by Barclays
Privia Health Is Maintained at Equal-Weight by Barclays
Express News | Privia Health Group Inc. : Barclays Cuts Target Price to $19 From $22
Privia Health Group (PRVA) Gets a Hold From Barclays
Privia Health Is Maintained at Buy by Truist Securities
Privia Health Is Maintained at Buy by Truist Securities
What 12 Analyst Ratings Have To Say About Privia Health Gr
Ratings for Privia Health Gr (NASDAQ:PRVA) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.Summarizing their recent assessments, the table b
Express News | Privia Health Group Inc : Truist Securities Cuts Target Price to $24 From $28
Truist Securities Adjusts Price Target on Privia Health Group to $24 From $28, Keeps Buy Rating
Privia Health Group (PRVA) has an average rating of buy and price targets ranging from $21 to $31, according to analysts polled by Capital IQ.
Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), IN8bio (INAB) and Privia Health Group (PRVA)
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2024 Earnings Call Transcript
Possible Bearish Signals With Privia Health Group Insiders Disposing Stock
Privia Health Group, Inc. (NASDAQ:PRVA) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When analyzing insider transactions, it is usually mor
Privia Health Is Maintained at Buy by Canaccord Genuity
Privia Health Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26
Privia Health Group Inc (PRVA) Q1 2024 Earnings: Mixed Results Amid Operational Growth
UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating
Privia Health Group (PRVA) has an average rating of Buy and price targets ranging from $21 to $31, according to analysts polled by Capital IQ. Price: 17.85, Change: -0.18, Percent Change: -1.00
Express News | Privia Health Group Inc : Evercore ISI Cuts Target Price to $23 From $25
Buy Rating Reaffirmed for Privia Health Group Amid Strong Financial Performance and Positive Growth Outlook
Express News | Privia Health Shares Are Trading Lower After the Company Reported a Q1 Revenue Miss
Privia Health | 10-Q: Quarterly report
Express News | Privia Health Reiterates FY24 Guidance; Revenue Of $1.6B-$1.675B, Est $2.844B
Express News | Privia Health Group Inc FY2024 Shr View $0.24, Rev View $2.84 Bln -- Lseg Ibes Data